ESR Supervisory Team
Dr Marcel Scheideler
Marcel Scheideler is Head of the Division Adipose Tissue Biology at the Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Germany. He studied in Mainz, Germany, and Toronto, Canada, completed his PhD from University of Mainz, Germany, spent his postdoctoral studies at Graz University of Technology, Austria, and completed there his habilitation. He gained ample experience of fat cell biology, including white and brown adipocyte development and function, transcriptome analysis and regulatory networks of mRNAs and microRNAs. He has published more than 50 papers in peer-reviewed journals, 8 book chapters, filed 2 patent applications with one of them issued.
Dr Natalia Pellegata
Natalia S. Pellegata is Head of the Division Neuroendocrinology at the Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Germany. She graduated in Biology (Genetics) at the University of Pavia, Italy, and completed her PhD studies in Cancer Genetics in Pavia and Leiden, The Netherlands. Dr. Pellegata carried out her postdoctoral studies at the University of California Irvine, USA, and at the Ohio State University, USA. She joined the Helmholtz Zentrum München in 2002, where she became group leader in 2007. She obtained her “Habilitation” at the Technical University of Munich (TUM), Faculty of Medicine, in 2011. Dr. Pellegata has a long-standing interest in studying the molecular mechanisms involved in cancer susceptibility and progression. Her studies led to the discovery of a novel multi-tumor syndrome (MEN4). Her current research interests focus on the identification and preclinical evaluation of novel therapies for various tumors. She has authored over 70 articles in peer-reviewed journals.
Early Stage Researchers
Adam Linford (UK) ESR Project 5
During my time studying at Derby I interned for Dr Gillian Knight in a project which aimed to determine the frequency of oral HPV infection within student populations. For my dissertation project I focused on the efficacy of several materials that when used as a coating allowed production of cancer spheroids within normal tissue culture wells.
My Masters degree at Sheffield in Translational Oncology focused on an in depth study of cancer research methods and current comprehensions of oncology research. For my research project I worked for six months within the Sheffield Myeloma Research Team (SMaRT), where I modelled the HSV 1716 oncolytic virus as a candidate for combined therapy in myeloma.
I am excited to be working with the wonderful team in Helmholtz Diabetes Center, Munich, where I will be able to develop my research skills in a way that contributes to wider scientific understanding. I look forward to tackling the challenges of the project head on.
Swapna Satam (IN) ESR Project 7
My name is Swapna Satam and I come from Mumbai (India), where I obtained my Bachelor’s in Biotechnology. Thereafter, I moved to Newcastle upon Tyne (UK), where I was awarded with a Master of Research in Cancer Biology. During this period, I have gained experience in RNA, molecular and cancer biology. Now, I am a PhD student at the Institute for Diabetes and Cancer IDC Helmholtz Center Munich, Germany. My research focuses on remote and local control of tumour microenvironment & metabolism through adipocyte Trib-expression. Here, I expect to extend my overall knowledge in cancer biology as well as acquire experience in working with animal models. Finally, I hope to work different universities and institutes through this TRAIN programme and expand my network